Ventris Medical earned FDA clearance to use its Backpack bone graft in intervertebral disc space.
The bone graft earned its first FDA nod in January. Backpack is offered in two versions — one with Allocell AF allograft fibers and one with surface activated amplify granules, according to an April 9 news release. Both versions feature a collagen mesh pouch filled with material.
“This graft containment technology is the first of its kind and represents a huge step forward in the bone graft technology available in today’s market,” Russell Cook, CEO of Ventris Medical, said in the release. “Backpack combines two heavily studied components; osteoinductive allograft fibers and our patented surface activated biphasic mineral components and places them in a biologic containment system providing an anti-migration feature not found in any other bone graft offering.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
